Recombinant HIV envelope expressed in an α-glucosidase I-deficient CHO cell line and its parental cell line in the presence of 1-deoxynojirimycin is functional

Virology

Volumn 231, Issue 1, 1997, Pages 89-95

  Fenouillet, Emmanuel ^a   Papandréou, Marie Jeanne ^a   Jones, Ian M ^b  

^a CNRS   (France)

^b CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYNOJIRIMYCIN; ALPHA GLUCOSIDASE; RECOMBINANT PROTEIN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; VIRUS CELL INTERACTION;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; VACCINIA; VACCINIA VIRUS;

EID: 0030961435     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8505     Document Type: Article

References (32)

1. Balow J., Weissman J., Kearse K. Unique expression of major histocompatibility complex class I proteins in the absence of glucose trimming and calnexin association. J. Biol. Chem. 270:1995;29025-29029.
2. Dedera D., VanderHeyden N., Ratner L. Attenuation of HIV-1 infectivity by an inhibitor of oligosaccharide processing. AIDS Res. Hum. Retroviruses. 6:1990;785-794.
3. Deng H. K., Liu R., Ellmeier W., Choe S., Unumtaz D., Burkhardt M., Di Marzio P., Marmon S., Sutton R., Hill C. M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
4. Dragic T., Litwin V., Allaway G. P., Martin S. R., Huang Y., Nagashima K. A., Cayanan C., Maddon P., Koup R. A., Moore J. P., Paxton W. A. Nature. 381:1996;667-673.
5. Elbein A. D. Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Annu. Rev. Biochem. 56:1987;497-534.
6. Fenouillet E., Gluckman J. C. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein. J. Gen. Virol. 72:1991;1919-1926.
7. Fenouillet E., Jones I., Powell B., Kiény M. P., Gluckman J. C. Functional role of the glycan cluster of HIV-1 transmembrane glycoprotein gp41. J. Virol. 67:1993;150-160.
8. Fenouillet E., Gluckman J. C., Jones I. M. Functions of HIV envelope glycans. Trends Biochem. Sci. 19:1994;65-70.
9. Fenouillet E., Jones I. M. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160. J. Gen. Virol. 76:1995;1509-1515.
10. Fenouillet E., Jones I. M. The hyperglycosylation of HIV envelope: An opportunity to alter virus infectivity? Perspect. Drug Disc. Design. 5:1996;203-212.
11. Fenouillet E., Miquelis R., Drillien R. Biological properties of recombinant HIV envelope synthesized in glycosylation mutant CHO cell lines. Virology. 218:1996;224-231.
12. Fischer P. B., Karlsson G. B., Butters T. D., Dwek R. A., Platt F. M. N butyldeoxynojirimycin-mediated inhibition of HIV entry correlates with changes in antibody recognition of the V1/V2 region of gp120. J. Virol. 70:1996;7143-7152.
13. Fisher P. B., Collin M., Karlsson G. B., James W., Butters T. D., Davis S. J., Gordon S., Dwek R. A., Platt F. M. The α-glucosidase inhibitorN. J. Virol. 69:1995;5791-5797.
14. Fujimoto K., Kornfeld R. α-Glucosidase II-deficient cells use endo-mannosidase as a bypass route for N-linked oligosaccharide processing. J. Biol. Chem. 266:1991;3571-3578.
15. Geyer H., Holschbach C., Hunsmann G., Schneider J. Carbohydrates of human immunodeficiency virus. J. Biol. Chem. 263:1988;11760-11767.
16. Gruters R. A., Neefjes J., Tersmette M., De Goede R. E. V., Huisman G., Miedema R., Ploegh H. L. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature (London). 330:1987;74-77.
17. Jones I., Jacob G. S. Anti-HIV drug mechanism. Nature. 352:1991;198.
18. Kornfeld R., Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 5:1985;631-664.
19. Llewellyn D. H., Kendall J. M., Sheikh N., Campbell A. K. Induction of calreticulin expression in HeLa cells by depletion of the endoplasmic reticulum Ca store and inhibition of N-linked glycosylation. Biochem. J. 318:1996;555-560.
20. Montefiori D. C., Robinson W. E., Mitchell W. M. Role of N glycosylation in pathogenesis of HIV-1. Proc. Natl. Acad. Sci. USA. 85:1988;9248-9252.
21. Moore J. P., Jameson B. A., Weiss R. A., Sattentau Q. The HIV-cell fusion reaction. Viral Fusion Mechanisms. 1993;CRC Press, Boca Raton. p. 230-289.
22. Otteken A., Moss B. Calreticulin interacts with newly synthesized HIV-1 envelope glycoprotein, suggesting a chaperone function similar to that of calnexin. J. Biol. Chem. 271:1996;97-103.
23. Pal R., Kalyanaraman V. S., Hoke G., Sarnghadaran M. G. Processing and secretion of envelope glycoproteins of HIV-1 in the presence of trimming glucosidase inhibitor deoxynojirimycin. Intervirology. 30:1989a;27-35.
24. Pal R., Hoke G., Sarnghadaran M. G. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 86:1989b;3384-3388.
25. Parent J. B., Yeo T. K., Yeo K. T., Olden K. Differential effects of 1-deoxynojirimycin on the intracellular transport of secretory glycoproteins of human hepatoma cells in culture. Mol. Cell. Biochem. 72:1986;21-33.
26. Ratner L. Glucosidase inhibitors for treatment of HIV-1 infection. AIDS Res. Hum. Retroviruses. 8:1992;165-173.
27. Ratner L., Vander Heyden N., Dedera D. Inhibition of HIV and SIV infectivity by blockade of α-glucosidase activity. Virology. 181:1991;180-192.
28. Ray M. K., Yang J., Sundaram S., Stanley S. A novel glycosylation phenotype expressed by Lec23, a chinese hamster ovary mutant deficient in α-glucosidase I. J. Biol. Chem. 266:1991;22818-22825.
29. Reitman M. L., Trowbridge I. S., Kornfeld S. A lectin resistant mouse lymphoma cell line is deficient in glucosidase II, a glycoprotein processing enzyme. J. Biol. Chem. 256:1982;5299-5303.
30. Stanley P. Use of mammalian cell mutants to study the functions of N- and O-linked glycosylation. Cell Surface and Extracellular Glycoconjugates. 1993;Academic Press, San Diego.
31. Tarentino A. L., Trimble R. B., Plummer T. H. Enzymatic approaches for studying the structure, synthesis, and processing of glycoproteins. Methods Cell Biol. 32:1989;111-139.
32. Tierney M., Pottage J., Kessler H., Fischl M., Richman D., Merigan T., Powderly W., Smith S., Karim A., Sherman J., Hirsch M. The tolerability and pharmacokinetics ofN. J. AIDS. 10:1995;549-553.